Journal of Immunotherapy

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Richard E. Royal, Catherine Lévy, Keli Turner et al. · 2010 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +14

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Richard A. Morgan, Nachimuthu Chinnasamy, Daniel Abate‐Daga et al. · 2013 · 1.1K citations

Life Sciences, Immunology, Neurology +17

Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients

Mark E. Dudley, John R. Wunderlich, Thomas E. Shelton et al. · 2003 · 709 citations

Life Sciences, Immunology, Oncology +17

Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula et al. · 2007 · 695 citations · Full text

Life Sciences, Immunology, Oncology +17

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

Dung T. Le, Eric R. Lutz, Jennifer N. Uram et al. · 2013 · 554 citations

Medicine, Oncology, Pharmacology +17